Blinatumomab for Acute Lymphoblastic Leukemia

N Engl J Med. 2017 Jun 8;376(23):e49. doi: 10.1056/NEJMc1704012.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Bispecific / therapeutic use*
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

  • Antibodies, Bispecific
  • blinatumomab